JP

John Pacifico

President, Chief Executive Officer, and Board Member of Abyrx, Inc. | General Partner at Canaan Partners | Founder and Chairman of Kairuku, Inc.

New York City Metropolitan Area

Invests in

Stages:

  • Min Investment:

    $250,000.00
  • Max Investment:

    $20,000,000.00
  • Target Investment:

    $10,000,000.00

Work Experience

2018

  • General Partner

    2018

    Early-stage venture capital investment firm.

2013

  • President, Chief Executive Officer, and Member of the Board of Directors

    2013

    Developer of biosurgical technologies.

  • Founder and Chairman

    2013

    SaaS solution to optimize distribution of medical products and information share.

  • Board Member

    2021

    Developing new pharmaceuticals to treat cancers.

  • Board Member

    2020

    Developing new pharmaceuticals to treat neurodegenerative disorders.

2021

  • Board Member

    2021

    Cybersecurity company enabling continuous / real-time visibility and insights into user access across enterprise technology systems.

2007 - 2013

  • President, Chief Executive Officer, and Member of the Board of Directors

    2007 - 2013

    Targeted drug delivery products for use during surgical procedures.

2000 - 2007

  • Venture Capitalist

    2000 - 2007

    Early-stage venture capital investment firm.